Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
It achieves this by reducing oxidative stress and inflammation, as evidenced by decreased levels of inflammatory cytokines and oxidative markers in lung tissues
Initially, the TlpB receptor on host cells is triggered by chemical signals, promoting a chemotactic response toward the gastric epithelium ( Helicobacter pylori navigates through the acidic environment via its flagella, avoiding direct gastric acid-induced damage, and after traversing the relatively neutral mucus layer, it firmly adheres to gastric epithelial cells ( Helicobacter pylori secretes urease, which hydrolyzes urea to produce ammonia and carbon dioxide, locally neutralizing gastric acid and creating a microenvironment favorable for its survival ( H
doi: 10.1093/jn/nxab322 19
Your PlexusDx provider can discuss whether switching to IUD, implant, or other non-hormonal options fits your medical profile and preferences
